NJ jury awards $25M to Ala. man in Accutane suitAssociated PressFeb. 23, 2010 |
From Aid to Dependency: Israeli Agent Reveals the Real Goal of 'Merging' U.S. and Israeli Militaries
ADL, Jewish Groups Lobby California to Classify Jews as a Race, 'Not Just a Faith'
House Passes NDAA With Section 219 Aimed at 'Merging' U.S. and Israeli Militaries
U.S. Must Prep to 'Welcome Large Numbers of Jewish Refugees,' Pro-War Lobbyist Mark Dubowitz Says
Trump Welcomes 'The Highly Respected' Alan Dershowitz Into The GOP, Shills His New Book
![]() ATLANTIC CITY, N.J. -- A New Jersey jury has hit the pharmaceutical company that makes Accutane with a $25.16 million judgment in a lawsuit filed by an Alabama man who blamed the drug for his inflammatory bowel disorder. Thirty-eight-year-old Andrew McCarrell of Moody, Ala., took the acne drug in his 20s. He says Hoffmann-La Roche Inc. failed to adequately warn of its side effects. McCarrell eventually had his colon removed. The compensatory damages award came Tuesday in a retrial. An appeals court overturned a $2.6 million judgment he won in May 2007. Continued |